At3g44120 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At3g44120 antibody; F26G5.70F-box/kelch-repeat protein At3g44120 antibody
Target Names
At3g44120
Uniprot No.

Q&A

What is At3g44120 Antibody and what protein does it target in Arabidopsis thaliana?

At3g44120 Antibody (product code CSB-PA864884XA01DOA) is a research-grade antibody that specifically targets the protein encoded by the At3g44120 gene in Arabidopsis thaliana (Mouse-ear cress). This antibody recognizes the protein identified by UniProt accession number Q9LXQ1 . The At3g44120 gene encodes a protein that is part of the plant's molecular machinery, and studying this protein through antibody detection helps researchers understand fundamental plant cellular processes. The antibody is available in two different volume options: 2ml and 0.1ml, allowing flexibility based on experimental scale and requirements .

What validated experimental applications is At3g44120 Antibody suitable for?

At3g44120 Antibody has been validated for several key molecular biology techniques commonly employed in plant research, including:

  • Western blotting for protein expression analysis

  • Immunoprecipitation for protein-protein interaction studies

  • Immunohistochemistry for tissue localization

  • Immunofluorescence for subcellular localization

  • ELISA for quantitative protein detection

When designing experiments, researchers should consider that different techniques require specific optimizations of antibody concentration, incubation conditions, and detection methods. Similar to other research antibodies targeting Arabidopsis proteins, experimental design should include appropriate controls to validate specificity and minimize background signal .

How should researchers interpret variable binding results across different experimental conditions?

Variable binding results with At3g44120 Antibody may stem from several factors. First, consider that antibody binding occurs within strict conformational constraints, similar to other biological recognition processes. When experiencing inconsistent results, systematically evaluate:

  • Sample preparation methods and protein denaturation conditions

  • Buffer composition and pH variations

  • Incubation temperatures and times

  • Blocking reagents and their effectiveness

  • Cross-reactivity with structurally similar proteins

Antibody accessibility to target epitopes can be sterically restricted under certain experimental conditions, as demonstrated in other antibody binding studies . Therefore, researchers should methodically optimize binding conditions by testing multiple parameters simultaneously through controlled experimental designs with appropriate variables .

How should I design robust experiments with proper controls when using At3g44120 Antibody?

Designing robust experiments with At3g44120 Antibody requires systematic planning following established experimental design principles. Begin by clearly identifying your research questions and formulating testable hypotheses about the target protein's function or expression . Your experimental design should include:

  • Independent Variables: Factors you will manipulate, such as treatment conditions, plant developmental stages, or environmental stressors.

  • Dependent Variables: Measurements of protein expression, localization, or interaction that will be assessed using the antibody.

  • Controlled Variables: Factors kept constant across experimental conditions.

  • Essential Controls:

    • Negative controls: Wild-type samples, secondary antibody-only controls

    • Positive controls: Recombinant protein standards

    • Knockout/knockdown lines: For antibody specificity validation

What methodological approaches can reduce experimental variability when working with plant antibodies?

To minimize experimental variability when working with At3g44120 Antibody in plant systems, implement these methodological approaches:

  • Standardize sample collection: Harvest plant tissues at consistent developmental stages and time points.

  • Optimize protein extraction:

    • Use fresh extraction buffers with appropriate protease inhibitors

    • Maintain consistent sample-to-buffer ratios

    • Standardize tissue disruption methods

    • Process samples at constant temperatures

  • Develop a reproducible blocking strategy:

    • Test multiple blocking agents (BSA, milk proteins, commercial blockers)

    • Optimize blocking time and temperature

    • Consider species-specific blockers to reduce background

  • Implement technical replicates: Include at least three technical replicates per biological sample to account for procedural variation.

  • Ensure consistent antibody handling:

    • Aliquot antibody stocks to minimize freeze-thaw cycles

    • Standardize dilution protocols

    • Use consistent incubation conditions

By implementing these approaches, researchers can establish reliable systems for investigating At3g44120 protein dynamics across different experimental conditions .

How can researchers optimize antibody concentration for different experimental techniques?

Optimizing At3g44120 Antibody concentration is a critical step for obtaining specific signals while minimizing background. The following methodological approach is recommended:

  • Perform titration experiments:

    • For Western blotting: Test dilution series (1:500, 1:1000, 1:2000, 1:5000)

    • For immunohistochemistry: Test dilution series (1:100, 1:250, 1:500, 1:1000)

    • For ELISA: Create standard curves with dilutions from 1:100 to 1:10,000

  • Consider signal-to-noise ratio:

    • Calculate the ratio between specific signal and background

    • Plot signal-to-noise against antibody concentration

    • Select the concentration providing maximum signal with minimal background

  • Validate across sample types:

    • Test optimized concentration across different tissue types

    • Verify consistency across developmental stages

    • Confirm specificity using genetic controls (knockout lines)

This systematic optimization is particularly important for plant antibodies, which may show variable specificity depending on tissue type and experimental conditions .

What factors might contribute to inconsistent results with At3g44120 Antibody?

Inconsistent results with At3g44120 Antibody can stem from multiple factors related to both the antibody itself and experimental conditions:

  • Antibody-related factors:

    • Lot-to-lot variability

    • Antibody degradation from improper storage

    • Freeze-thaw cycle damage to antibody structure

  • Sample preparation issues:

    • Incomplete protein extraction from plant tissues

    • Protein degradation during sample processing

    • Variable denaturation affecting epitope exposure

    • Inconsistent fixation protocols for immunohistochemistry

  • Technical variables:

    • Temperature fluctuations during incubation steps

    • Inconsistent washing procedures

    • Variable transfer efficiency in Western blotting

    • Inconsistent blocking effectiveness

  • Biological variables:

    • Plant growth conditions affecting protein expression

    • Developmental stage variations

    • Stress responses altering protein conformation or modification

When troubleshooting, systematically test each variable through controlled experiments, changing only one factor at a time to identify the source of inconsistency .

How can researchers validate the specificity of At3g44120 Antibody?

Validating antibody specificity is crucial for reliable research outcomes. For At3g44120 Antibody, implement the following comprehensive validation approach:

  • Genetic validation:

    • Test the antibody on knockout/knockdown lines lacking the At3g44120 gene

    • Evaluate signal in overexpression lines with increased target abundance

    • Compare signal patterns across ecotypes with known protein variants

  • Biochemical validation:

    • Perform peptide competition assays using blocking peptides

    • Conduct immunoprecipitation followed by mass spectrometry to confirm target identity

    • Compare results with alternative antibodies targeting different epitopes of the same protein

  • Cross-reactivity testing:

    • Assess binding to recombinant proteins with similar sequences

    • Test reactivity in related plant species

    • Evaluate specificity through protein array technologies

  • Validation across techniques:

    • Confirm consistent target recognition across multiple experimental approaches

    • Verify subcellular localization matches known distribution patterns

    • Compare results with published data on At3g44120 protein

This multi-layered validation approach ensures that experimental observations genuinely reflect the biology of the target protein rather than artifacts .

What statistical approaches are appropriate for analyzing quantitative data generated using At3g44120 Antibody?

  • Preliminary data assessment:

    • Test for normal distribution using Shapiro-Wilk or Kolmogorov-Smirnov tests

    • Evaluate homogeneity of variance with Levene's test

    • Identify and address outliers using standardized residuals or Cook's distance

  • Statistical tests for comparison:

    • For normally distributed data: t-tests (two groups) or ANOVA (multiple groups)

    • For non-normally distributed data: Mann-Whitney U test or Kruskal-Wallis test

    • For repeated measures: Repeated measures ANOVA or mixed-effects models

  • Multiple testing corrections:

    • Apply Bonferroni correction for stringent control of false positives

    • Consider Benjamini-Hochberg procedure for controlling false discovery rate

    • Use Tukey's HSD or Dunnett's test for post-hoc comparisons

  • Effect size reporting:

    • Calculate Cohen's d or Hedges' g for parametric comparisons

    • Determine η² (eta-squared) or partial η² for ANOVA analyses

    • Report confidence intervals alongside p-values

Proper statistical analysis ensures that observed differences in protein expression or localization detected with At3g44120 Antibody reflect genuine biological phenomena rather than random variation .

How can At3g44120 Antibody be effectively utilized in protein interaction studies?

At3g44120 Antibody can be leveraged for studying protein-protein interactions through several sophisticated methodological approaches:

  • Co-immunoprecipitation (Co-IP):

    • Use At3g44120 Antibody to pull down the target protein and associated complexes

    • Optimize lysis conditions to preserve native protein interactions

    • Implement stringent washing protocols to minimize non-specific binding

    • Analyze precipitated complexes through Western blotting or mass spectrometry

  • Proximity ligation assay (PLA):

    • Combine At3g44120 Antibody with antibodies against potential interacting partners

    • Visualize interactions through fluorescent signal generation when proteins are in close proximity

    • Quantify interaction frequency across different cellular compartments or conditions

  • Bimolecular fluorescence complementation (BiFC) validation:

    • Use antibody-based detection to validate interactions identified through BiFC

    • Confirm expression levels of fusion proteins using At3g44120 Antibody

    • Compare interaction patterns with native protein distribution

  • Chromatin immunoprecipitation (ChIP):

    • Apply At3g44120 Antibody to investigate protein-DNA interactions if the target has DNA-binding properties

    • Optimize crosslinking conditions for plant tissues

    • Validate ChIP efficiency through quantitative PCR of known binding regions

These approaches allow researchers to build comprehensive interaction networks for the At3g44120 protein, providing insights into its functional roles in plant cellular processes .

What considerations are important when using At3g44120 Antibody for localization studies in plant tissues?

When using At3g44120 Antibody for localization studies in plant tissues, several technical considerations are critical for accurate results:

  • Fixation optimization:

    • Test multiple fixatives (paraformaldehyde, glutaraldehyde, methanol)

    • Optimize fixation time and temperature for different tissue types

    • Evaluate epitope preservation through controlled comparison studies

  • Tissue permeabilization:

    • Develop tissue-specific protocols for cell wall digestion

    • Balance permeabilization for antibody access while preserving tissue architecture

    • Consider using detergents at varying concentrations (0.1-0.5% Triton X-100)

  • Signal amplification strategies:

    • Implement tyramide signal amplification for low-abundance proteins

    • Use quantum dot conjugates for enhanced sensitivity and stability

    • Consider multiplex detection with spectral unmixing for co-localization studies

  • Three-dimensional analysis:

    • Collect z-stack images with appropriate step sizes

    • Apply deconvolution algorithms to improve signal resolution

    • Quantify co-localization using appropriate coefficients (Pearson's, Manders')

  • Controls for autofluorescence:

    • Include unstained tissue controls to assess natural autofluorescence

    • Consider spectral imaging to distinguish antibody signal from autofluorescence

    • Implement computational approaches to subtract autofluorescence signals

The sterically restricted access of antibody molecules to certain cellular compartments should be considered when interpreting negative results, as physical constraints may limit binding even when the target protein is present .

How can At3g44120 Antibody be integrated into multi-omics research approaches?

Integrating At3g44120 Antibody into multi-omics research requires methodological strategies that connect antibody-based protein detection with other data types:

  • Proteomics integration:

    • Use antibody-based enrichment prior to mass spectrometry

    • Compare protein abundance measured by At3g44120 Antibody with global proteomics data

    • Identify post-translational modifications through immunoprecipitation followed by modification-specific analysis

  • Transcriptomics correlation:

    • Correlate protein levels detected by At3g44120 Antibody with mRNA expression data

    • Identify discrepancies suggesting post-transcriptional regulation

    • Design time-course experiments to capture expression dynamics at both levels

  • Metabolomics connections:

    • Use At3g44120 Antibody to manipulate protein function through immunodepletion

    • Correlate protein abundance with metabolite profiles

    • Identify metabolic pathways potentially regulated by the target protein

  • Phenomics applications:

    • Correlate protein expression patterns with phenotypic traits

    • Use antibody-based imaging to connect protein localization with cellular phenotypes

    • Develop high-throughput screening approaches using automated immunostaining

  • Data integration frameworks:

    • Implement computational pipelines to integrate antibody-based quantification with other omics datasets

    • Apply machine learning approaches to identify correlative patterns

    • Develop network models incorporating protein interaction data

This integrated approach provides a comprehensive understanding of At3g44120 protein function within the broader context of plant cellular systems .

What emerging technologies might enhance the application of At3g44120 Antibody in plant research?

Several emerging technologies show promise for expanding the utility of At3g44120 Antibody in plant research:

  • Super-resolution microscopy:

    • Apply STED, PALM, or STORM techniques for nanoscale localization

    • Resolve protein distribution within subcellular compartments

    • Visualize protein clustering and microdomains

  • Single-cell proteomics:

    • Combine flow cytometry with antibody detection for single-cell analysis

    • Develop microfluidic approaches for high-throughput single-cell protein quantification

    • Correlate protein expression with single-cell transcriptomics

  • Antibody engineering:

    • Develop smaller antibody fragments (nanobodies) for improved tissue penetration

    • Create bifunctional antibodies for simultaneous detection of multiple targets

    • Engineer pH-sensitive antibodies for monitoring protein trafficking

  • In vivo imaging approaches:

    • Adapt antibody fragments for live-cell imaging applications

    • Develop methodologies for non-destructive protein tracking in living plants

    • Create plant-specific reporters based on antibody recognition domains

  • Computational antibody optimization:

    • Apply machine learning for epitope prediction and antibody design

    • Develop algorithms for improved antibody specificity

    • Create databases of validated antibody applications in plant systems

Researchers should consider how these emerging approaches might be adapted for their specific experimental questions when planning long-term research programs involving At3g44120 Antibody .

How should researchers approach contradictory results between antibody-based detection and other experimental methods?

When faced with contradictory results between At3g44120 Antibody detection and other methods, researchers should implement a systematic reconciliation approach:

  • Validation of both methodologies:

    • Reassess the specificity of the antibody through comprehensive controls

    • Evaluate the reliability of the alternative method with appropriate standards

    • Consider whether methodological limitations might explain the discrepancies

  • Biological explanations:

    • Investigate potential post-translational modifications affecting antibody recognition

    • Consider alternative splicing or protein isoforms detected differentially

    • Evaluate protein stability and turnover rates in different experimental contexts

  • Experimental design considerations:

    • Conduct side-by-side comparisons under identical conditions

    • Design time-course experiments to capture dynamic changes

    • Implement factorial experimental designs to identify interacting factors

  • Reconciliation strategies:

    • Develop a third independent method as a tiebreaker

    • Consider whether both results might be correct in different contexts

    • Implement computational modeling to explain apparently contradictory observations

  • Transparent reporting:

    • Document all contradictory results thoroughly

    • Report methodological details that might explain discrepancies

    • Consider publishing findings even when contradictions remain unresolved

This systematic approach transforms contradictions into opportunities for deeper understanding of the biological system and methodological refinement .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.